COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Amid waning COVID-19 threat, CDC Director Walensky resigns
By
Alicia Lasek
May 07, 2023
As the threat of COVID-19 fades, a key figure in the Biden Administration’s pandemic fight is stepping down.
Study pinpoints factors than cut residents’ risk of omicron infection
By
Alicia Lasek
Mar 30, 2023
A study of nearly 1,000 residents underscores the importance of vaccine type and number of doses in maintaining protective immunity, and reducing the risk of breakthrough infections, investigators say.
Healthcare use rises in the 6 months after severe COVID recovery: study
By
Alicia Lasek
Aug 14, 2022
Persistent post-COVID conditions, including alopecia (hair loss), bronchitis and pulmonary embolism, have driven excess healthcare usage, investigators say.
Anticoagulants advised following certain COVID-19 acute-care stays
By
Alicia Lasek
Nov 29, 2021
Clinicians disagree about the need for continued anticoagulation therapy to reduce blood clot risks following COVID-19 hospitalization. A new study suggests that patients with certain medical histories...
Study confirms effectiveness of bivalent COVID booster; AHCA helps spread word
By
Alicia Lasek
Dec 22, 2022
New data and support materials are available for clinicians who want to encourage more residents and staff to get the updated COVID-19 booster shot.
Long-term care left behind in race to nab COVID monoclonal antibodies: report
Nov 02, 2021
Delayed shipments of antibody doses are putting residents’ lives at risk after federal authorities barred direct orders of the drugs, LTC clinicians say.
National survey tells story of COVID in assisted living
By
Alicia Lasek
Aug 19, 2021
New industry data from the CDC’s National Center for Health Statistics details how COVID-19 affected assisted living communities across the country during the height of the pandemic.
Most COVID-19 antibody treatments given in assisted living, analysts find
By
Alicia Lasek
Feb 22, 2021
Fully 67% of monoclonal antibody treatments have been administered in assisted living communities. Health officials would like to encourage greater use.